{"id":"W2126270742","doi":"10.1016/j.lungcan.2009.11.018","title":"Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology","year":2009,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pemetrexed; Medicine; Erlotinib; Gefitinib; Oncology; Cetuximab; Bevacizumab; Internal medicine; Lung cancer; Adenocarcinoma; Clinical trial; Chemotherapy; Cancer; Epidermal growth factor receptor; Cisplatin; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001925188,0.0007675998,0.002246941,0.001356468,0.0002146203,0.0009493442,0.0009659597,0.0012761,0.002279451],"category_scores_gemma":[0.001537924,0.0003367816,0.001027109,0.001792519,0.0003018884,0.001129315,0.0004763213,0.001979954,0.0008593562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009759138,"about_ca_system_score_gemma":0.001455004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002016846,"about_ca_topic_score_gemma":0.006508693,"domain_scores_codex":[0.9996349,0.0000761254,0.00007198258,0.0000533113,0.0001347716,0.0000288935],"domain_scores_gemma":[0.9989675,0.0005284008,0.0001772833,0.00001498467,0.0002632822,0.00004842323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002188433,0.00006560803,0.0002446853,0.02561851,0.0002269526,0.0001429825,0.00003602561,0.0004874095,0.0009292301,0.0007186921,0.05090847,0.9204026],"study_design_scores_gemma":[0.0002244341,0.0003737054,0.003423716,0.01409465,0.001308377,0.001232613,0.00008057127,0.000295294,0.0008533392,0.0008211361,0.9772567,0.00003548446],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001094166,0.9984224,0.000061921,0.0007500867,0.0002469172,0.000005633593,0.00002336681,0.000003644516,0.0003767072],"genre_scores_gemma":[0.0009016364,0.9975801,0.0001927957,0.0007477989,0.000235673,0.00000793634,0.00005879965,0.000001665195,0.0002736667],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002279451,"threshold_uncertainty_score":0.01018149,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04081135753217011,"score_gpt":0.4496065279671237,"score_spread":0.4087951704349536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}